Shares of biotech firm Anavex Life Sciences Corp. (NASDAQ: AVXL) fell more than 17% in today’s trading session. This can be attributed to its Q4 earnings results.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
- Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week.
The company currently has no sales, meaning that analysts are estimating its cash burn. Earnings per share came in at -$0.18, which was lower than the -$0.17 that was expected.
Is AVXL Stock a Good Investment?
AVXL stock has a Strong Buy consensus rating based on four Buys assigned in the past three months. The average AVXL stock price target of $39.25 implies almost 300% upside potential.
